Pfizer receives CHMP positive opinion for novel COVID-19 oral treatment
Summary : Pfizer Inc. (NYSE: PFE) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency…
Summary : Pfizer Inc. (NYSE: PFE) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency…
PF-07321332 & Ritonavir (Paxlovid): Pfizer Gets CDSCO Panel Nod To Study For COVID Treatment. The Central Drugs Standard Control Organisation(CDSCO) under Directorate General…
KEYPOINTS: Pfizer Inc allow generic manufacturers to supply its experimental antiviral Covid-19 pill to 95 low- and middle-income countries. This will be…
KEYPOINTS: Pfizer announced that its oral antiviral cut the risk of hospitalization or death by 89% in an interim analysis of the…